Submitting an Abbreviated New Drug Application to the United States Food and Drug Administration incurs a base fee of approximately $365,000

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.